Article cognitive behavioral therapy for insomnia outcomes in women after primary breast cancer treatment: A randomized, controlled trial

Ellyn E. Matthews, Ann Malone Berger, Sarah J. Schmiege, Paul F. Cook, Michaela S. McCarthy, Camille M. Moore, Mark S. Aloia

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Purpose/Objectives: To examine the effect of cognitive-behavioral therapy for insomnia (CBTI) on sleep improvement, daytime symptoms, and quality of life (QOL) in breast cancer survivors (BCSs) after cancer treatment. Design: A prospective, longitudinal, randomized, controlled trial. Setting: Oncology clinics, breast cancer support groups, and communities in Colorado. Sample: 56 middle-Aged BCSs with chronic insomnia. Methods: Women were randomly assigned to CBTI or behavioral placebo treatment (BPT) and completed measures of sleep, QOL, functioning, fatigue, and mood at baseline, postintervention, and at three- and six-month follow-ups. Main Research Variables: Sleep outcomes (e.g., sleep efficiency, sleep latency, total sleep time, wake after sleep onset, number of nightly awakenings); secondary variables included sleep medication use, insomnia severity, QOL, physical function, cognitive function, fatigue, depression, anxiety, and sleep attitudes or knowledge. Findings: Sleep efficiency and latency improved more in the CBTI group than the BPT group; this difference was maintained during follow-up. Women in the CBTI group had less subjective insomnia, greater improvements in physical and cognitive functioning, positive sleep attitudes, and increased sleep hygiene knowledge. No group differences in improvement were noted relative to QOL, fatigue, or mood. Conclusions: Nurse-delivered CBTI appears to be beneficial for BCSs' sleep latency/efficiency, insomnia severity, functioning, sleep knowledge, and attitudes more than active placebo, with sustained benefit over time. Implications for Nursing: Oncology nurses are in a unique position to identify insomnia in cancer survivors. When sleep disturbances become chronic, nurses need to make recommendations and referrals.

Original languageEnglish (US)
Pages (from-to)241-253
Number of pages13
JournalOncology nursing forum
Volume41
Issue number3
DOIs
StatePublished - May 2014

Fingerprint

Sleep Initiation and Maintenance Disorders
Cognitive Therapy
Sleep
Randomized Controlled Trials
Breast Neoplasms
Therapeutics
Survivors
Quality of Life
Fatigue
Nurses
Placebos
Oncology Nursing
Self-Help Groups
Cognition
Neoplasms
Referral and Consultation
Anxiety

Keywords

  • Breast cancer
  • Fatigue
  • Late effects of cancer treatment
  • Outcomes research
  • Survivorship

ASJC Scopus subject areas

  • Oncology(nursing)

Cite this

Article cognitive behavioral therapy for insomnia outcomes in women after primary breast cancer treatment : A randomized, controlled trial. / Matthews, Ellyn E.; Berger, Ann Malone; Schmiege, Sarah J.; Cook, Paul F.; McCarthy, Michaela S.; Moore, Camille M.; Aloia, Mark S.

In: Oncology nursing forum, Vol. 41, No. 3, 05.2014, p. 241-253.

Research output: Contribution to journalArticle

Matthews, Ellyn E. ; Berger, Ann Malone ; Schmiege, Sarah J. ; Cook, Paul F. ; McCarthy, Michaela S. ; Moore, Camille M. ; Aloia, Mark S. / Article cognitive behavioral therapy for insomnia outcomes in women after primary breast cancer treatment : A randomized, controlled trial. In: Oncology nursing forum. 2014 ; Vol. 41, No. 3. pp. 241-253.
@article{ea8b1798a13040d985dc2271bd5fa595,
title = "Article cognitive behavioral therapy for insomnia outcomes in women after primary breast cancer treatment: A randomized, controlled trial",
abstract = "Purpose/Objectives: To examine the effect of cognitive-behavioral therapy for insomnia (CBTI) on sleep improvement, daytime symptoms, and quality of life (QOL) in breast cancer survivors (BCSs) after cancer treatment. Design: A prospective, longitudinal, randomized, controlled trial. Setting: Oncology clinics, breast cancer support groups, and communities in Colorado. Sample: 56 middle-Aged BCSs with chronic insomnia. Methods: Women were randomly assigned to CBTI or behavioral placebo treatment (BPT) and completed measures of sleep, QOL, functioning, fatigue, and mood at baseline, postintervention, and at three- and six-month follow-ups. Main Research Variables: Sleep outcomes (e.g., sleep efficiency, sleep latency, total sleep time, wake after sleep onset, number of nightly awakenings); secondary variables included sleep medication use, insomnia severity, QOL, physical function, cognitive function, fatigue, depression, anxiety, and sleep attitudes or knowledge. Findings: Sleep efficiency and latency improved more in the CBTI group than the BPT group; this difference was maintained during follow-up. Women in the CBTI group had less subjective insomnia, greater improvements in physical and cognitive functioning, positive sleep attitudes, and increased sleep hygiene knowledge. No group differences in improvement were noted relative to QOL, fatigue, or mood. Conclusions: Nurse-delivered CBTI appears to be beneficial for BCSs' sleep latency/efficiency, insomnia severity, functioning, sleep knowledge, and attitudes more than active placebo, with sustained benefit over time. Implications for Nursing: Oncology nurses are in a unique position to identify insomnia in cancer survivors. When sleep disturbances become chronic, nurses need to make recommendations and referrals.",
keywords = "Breast cancer, Fatigue, Late effects of cancer treatment, Outcomes research, Survivorship",
author = "Matthews, {Ellyn E.} and Berger, {Ann Malone} and Schmiege, {Sarah J.} and Cook, {Paul F.} and McCarthy, {Michaela S.} and Moore, {Camille M.} and Aloia, {Mark S.}",
year = "2014",
month = "5",
doi = "10.1188/14.ONF.41-03AP",
language = "English (US)",
volume = "41",
pages = "241--253",
journal = "Oncology Nursing Forum",
issn = "0190-535X",
publisher = "Oncology Nursing Society",
number = "3",

}

TY - JOUR

T1 - Article cognitive behavioral therapy for insomnia outcomes in women after primary breast cancer treatment

T2 - A randomized, controlled trial

AU - Matthews, Ellyn E.

AU - Berger, Ann Malone

AU - Schmiege, Sarah J.

AU - Cook, Paul F.

AU - McCarthy, Michaela S.

AU - Moore, Camille M.

AU - Aloia, Mark S.

PY - 2014/5

Y1 - 2014/5

N2 - Purpose/Objectives: To examine the effect of cognitive-behavioral therapy for insomnia (CBTI) on sleep improvement, daytime symptoms, and quality of life (QOL) in breast cancer survivors (BCSs) after cancer treatment. Design: A prospective, longitudinal, randomized, controlled trial. Setting: Oncology clinics, breast cancer support groups, and communities in Colorado. Sample: 56 middle-Aged BCSs with chronic insomnia. Methods: Women were randomly assigned to CBTI or behavioral placebo treatment (BPT) and completed measures of sleep, QOL, functioning, fatigue, and mood at baseline, postintervention, and at three- and six-month follow-ups. Main Research Variables: Sleep outcomes (e.g., sleep efficiency, sleep latency, total sleep time, wake after sleep onset, number of nightly awakenings); secondary variables included sleep medication use, insomnia severity, QOL, physical function, cognitive function, fatigue, depression, anxiety, and sleep attitudes or knowledge. Findings: Sleep efficiency and latency improved more in the CBTI group than the BPT group; this difference was maintained during follow-up. Women in the CBTI group had less subjective insomnia, greater improvements in physical and cognitive functioning, positive sleep attitudes, and increased sleep hygiene knowledge. No group differences in improvement were noted relative to QOL, fatigue, or mood. Conclusions: Nurse-delivered CBTI appears to be beneficial for BCSs' sleep latency/efficiency, insomnia severity, functioning, sleep knowledge, and attitudes more than active placebo, with sustained benefit over time. Implications for Nursing: Oncology nurses are in a unique position to identify insomnia in cancer survivors. When sleep disturbances become chronic, nurses need to make recommendations and referrals.

AB - Purpose/Objectives: To examine the effect of cognitive-behavioral therapy for insomnia (CBTI) on sleep improvement, daytime symptoms, and quality of life (QOL) in breast cancer survivors (BCSs) after cancer treatment. Design: A prospective, longitudinal, randomized, controlled trial. Setting: Oncology clinics, breast cancer support groups, and communities in Colorado. Sample: 56 middle-Aged BCSs with chronic insomnia. Methods: Women were randomly assigned to CBTI or behavioral placebo treatment (BPT) and completed measures of sleep, QOL, functioning, fatigue, and mood at baseline, postintervention, and at three- and six-month follow-ups. Main Research Variables: Sleep outcomes (e.g., sleep efficiency, sleep latency, total sleep time, wake after sleep onset, number of nightly awakenings); secondary variables included sleep medication use, insomnia severity, QOL, physical function, cognitive function, fatigue, depression, anxiety, and sleep attitudes or knowledge. Findings: Sleep efficiency and latency improved more in the CBTI group than the BPT group; this difference was maintained during follow-up. Women in the CBTI group had less subjective insomnia, greater improvements in physical and cognitive functioning, positive sleep attitudes, and increased sleep hygiene knowledge. No group differences in improvement were noted relative to QOL, fatigue, or mood. Conclusions: Nurse-delivered CBTI appears to be beneficial for BCSs' sleep latency/efficiency, insomnia severity, functioning, sleep knowledge, and attitudes more than active placebo, with sustained benefit over time. Implications for Nursing: Oncology nurses are in a unique position to identify insomnia in cancer survivors. When sleep disturbances become chronic, nurses need to make recommendations and referrals.

KW - Breast cancer

KW - Fatigue

KW - Late effects of cancer treatment

KW - Outcomes research

KW - Survivorship

UR - http://www.scopus.com/inward/record.url?scp=84901005255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901005255&partnerID=8YFLogxK

U2 - 10.1188/14.ONF.41-03AP

DO - 10.1188/14.ONF.41-03AP

M3 - Article

C2 - 24650832

AN - SCOPUS:84901005255

VL - 41

SP - 241

EP - 253

JO - Oncology Nursing Forum

JF - Oncology Nursing Forum

SN - 0190-535X

IS - 3

ER -